Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Antibodies.com Europe AB
AB
Active
Org 5593880064
Kammakargatan 47, 111 24
Stockholm
Activities of agents involved in the wholesale of other particular products
· NACE 4618
Est. 2022
0 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of agents involved in the wholesale of other particular products
/
Antibodies.com Europe AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
3M
6M
9M
13M
8M
2023
11M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
7 768
10 943
Staff expenses
—
—
EBITDA
47
47
Depreciation & amort.
−0
−0
EBIT
47
47
Net financials
—
3
Profit before tax
47
51
Tax
−10
−10
Net profit
37
41
Balance sheet
SEK thousands
Item
2023
2024
Total assets
1 789
2 381
Equity
62
103
Long-term debt
0
0
Short-term debt
1 726
2 277
Total debt
1 726
2 277
Financial ratios
5-year trend
EBITDA margin
0.4%
This company
15.8%
Market median
-97% vs market
2023
2024
Equity ratio
4.3%
This company
38.2%
Market median
-89% vs market
2023
2024
Return on equity
39.8%
This company
18.4%
Market median
+116% vs market
2023
2024
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
2023
2024
Asset turnover
4.60×
This company
1.12×
Market median
+311% vs market
2023
2024
Debt / equity
22.12×
This company
0.62×
Market median
-3468% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-12-31
View
PDF
More on Antibodies.com Europe AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
